The number of treatment options is continuously increasing. New targeted drugs are available and new minimally invasive approaches to focused therapies are required. Diagnostics and treatment need to become more integrated.

We at Philips enable patient-specific care pathway selection, including available clinical trials, based on integrated patient diagnostic information with the goal to enhance patient care.

To ensure the best possible outcome it is important to assess how the cancer is responding to the selected therapy. If not responding as expected then a plan adaption may be considered as part of a personalized therapy regimen to ensure optimal outcomes. 

We at Philips provide systems and tools that support enable a workflow that increases access to cancer care and drives down cost while also improving patient experience. We do this to reduce unnecessary patient burden and cost of ineffective therapies.